Abstract
Immune gamma globulin (IgG) has a long history in the treatment of both primary immune deficiency and autoimmune disorders. Disease indications continue to expand and new-generation products increase the versatility of delivery. This review encompasses a historical perspective as well as current and future implications of human immune globulin for the treatment of immune-mediated illness.
from #ENT via xlomafota13 on Inoreader http://ift.tt/29xQTQU
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου